Arcutis Biotherapeutics, Inc.ARQTNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
21.74%
↓ 49% below average
Average (30q)
42.89%
Historical baseline
Range
High:634.28%
Low:-64.51%
Volatility
1629.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 21.74% |
| Q2 2025 | 23.78% |
| Q1 2025 | -7.73% |
| Q4 2024 | 59.45% |
| Q3 2024 | 45.04% |
| Q2 2024 | -37.75% |
| Q1 2024 | 266.47% |
| Q4 2023 | -64.51% |
| Q3 2023 | 634.28% |
| Q2 2023 | 86.62% |
| Q1 2023 | -6.08% |
| Q4 2022 | 308.41% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |